|
1
|
Zhang N, Wei X and Xu L: miR-150 promotes
the proliferation of lung cancer cells by targeting P53. FEBS Lett.
587:2346–2351. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Molina JR, Yang P, Cassivi SD, Schild SE
and Adjei AA: Non-small cell lung cancer: Epidemiology, risk
factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: The impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Boyero L, Sánchez-Palencia A, Miranda-León
MT, Hernández-Escobar F, Gómez-Capilla JA and Fárez-Vidal ME:
Survival, classifications, and desmosomal plaque genes in non-small
cell lung cancer. Int J Med Sci. 10:1166–1173. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shaoyan X, Juanjuan Y, Yalan T, Ping H,
Jianzhong L and Qinian W: Downregulation of EIF4A2 in
non-small-cell lung cancer associates with poor prognosis. Clin
Lung Cancer. 14:658–665. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vendetti FP and Rudin CM: Epigenetic
therapy in non-small-cell lung cancer: Targeting DNA
methyltransferases and histone deacetylases. Expert Opin Biol Ther.
13:1273–1285. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Adams RH, Betz H and Püschel AW: A novel
class of murine semaphorins with homology to thrombospondin is
differentially expressed during early embryogenesis. Mech Dev.
57:33–45. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Capparuccia L and Tamagnone L: Semaphorin
signaling in cancer cells and in cells of the tumor
microenvironment-two sides of a coin. J Cell Sci. 122:1723–1736.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Christensen C, Ambartsumian N, Gilestro G,
Thomsen B, Comoglio P, Tamagnone L, Guldberg P and Lukanidin E:
Proteolytic processing converts the repelling signal Sema3E into an
inducer of invasive growth and lung metastasis. Cancer Res.
65:6167–6177. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Adams RH, Lohrum M, Klostermann A, Betz H
and Püschel AW: The chemorepulsive activity of secreted semaphorins
is regulated by furin-dependent proteolytic processing. EMBO J.
16:6077–6086. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hattori M, Osterfield M and Flanagan JG:
Regulated cleavage of a contact-mediated axon repellent. Science.
289:1360–1365. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Esselens C, Malapeira J, Colome N, Casa l
C, Rodríguez-Manzaneque JC, Canals F and Arribas J: The cleavage of
semaphorin 3C induced by ADAMTS1 promotes cell migration. J Biol
Chem. 285:2463–2473. 2010. View Article : Google Scholar :
|
|
14
|
Browne K, Wang W, Liu RQ, Piva M and
O′Connor TP: Transmembrane semaphorin5B is proteolytically
processed into a repulsive neural guidance cue. J Neurochem.
123:135–146. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Potiron VA, Roche J and Drabkin HA:
Semaphorins and their receptors in lung cancer. Cancer Lett.
273:1–14. 2009. View Article : Google Scholar :
|
|
16
|
Chedotal A, Kerjan G and Moreau-Fauvarque
C: The brain within the tumor: New roles for axon guidance
molecules in cancers. Cell Death Differ. 12:1044–1056. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Behar O, Golden JA, Mashimo H, Schoen FJ
and Fishman MC: Semaphorin III is needed for normal patterning and
growth of nerves, bones and heart. Nature. 383:525–528. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hall KT, Boumsell L, Schultze JL,
Boussiotis VA, Dorfman DM, Cardoso AA, Bensussan A, Nadler LM and
Freeman GJ: Human CD100, a novel leukocyte semaphorin that promotes
B-cell aggregation and differentiation. Proc Natl Acad Sci USA.
93:11780–11785. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miao HQ, Soker S, Feiner L, Alonso JL,
Raper JA and Klagsbrun M: Neuropilin-1 mediates
collapsin-1/semaphorin III inhibition of endothelial cell motility:
Functional competition of collapsin-1 and vascular endothelial
growth factor-165. J Cell Biol. 146:233–242. 1999.PubMed/NCBI
|
|
20
|
Christensen CR, Klingelhofer J, Tarabykina
S, Hulgaard EF, Kramerov D and Lukanidin E: Transcription of a
novel mouse semaphorin gene, M-semaH, correlates with the
metastatic ability of mouse tumor cell lines. Cancer Res.
58:1238–1244. 1998.PubMed/NCBI
|
|
21
|
Chen R, Zhuge X, Huang Z, Lu D, Ye X, Chen
C, Yu J and Lu G: Analysis of SEMA3B methylation and expression
patterns in gastric cancer tissue and cell lines. Oncol Rep.
31:1211–1218. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gao X, Tang C, Shi W, Feng S, Qin W, Jiang
T and Sun Y: Semaphorin-3F functions as a tumor suppressor in
colorectal cancer due to regulation by DNA methylation. Int J Clin
Exp Pathol. 8:12766–12774. 2015.
|
|
23
|
Kruger RP, Aurandt J and Guan KL:
Semaphorins command cells to move. Nat Rev Mol Cell Biol.
6:789–800. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nagai H, Sugito N, Matsubara H, Tatematsu
Y, Hida T, Sekido Y, Nagino M, Nimura Y, Takahashi T and Osada H:
CLCP1 interacts with semaphorin 4B and regulates motility of lung
cancer cells. Oncogene. 26:4025–4031. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nasarre P, Kusy S, Constantin B,
Castellani V, Drabkin HA, Bagnard D and Roche J: Semaphorin SEMA3F
has a repulsing activity on breast cancer cells and inhibits
E-cadherin-mediated cell adhesion. Neoplasia. 7:180–189. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Castro-Rivera E, Ran S, Thorpe P and Minna
JD: Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast
cancer, whereas VEGF165 antagonizes this effect. Proc Natl Acad Sci
USA. 101:11432–11437. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tomizawa Y, Sekido Y, Kondo M, Gao B,
Yokota J, Roche J, Drabkin H, Lerman MI, Gazdar AF and Minna JD:
Inhibition of lung cancer cell growth and induction of apoptosis
after reexpression of 3p21.3 candidate tumor suppressor gene
SEMA3B. Proc Natl Acad Sci USA. 98:13954–13959. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Brambilla E, Constantin B, Drabkin H and
Roche J: Semaphorin SEMA3F localization in malignant human lung and
cell lines: A suggested role in cell adhesion and cell migration.
Am J Pathol. 156:939–950. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu TP, Tsai MH, Lee JM, Hsu CP, Chen PC,
Lin CW, Shih JY, Yang PC, Hsiao CK, Lai LC and Chuang EY:
Identification of a novel biomarker, SEMA5A, for non-small cell
lung carcinoma in nonsmoking women. Cancer Epidemiol Biomarkers
Prev. 19:2590–2597. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kolodkin AL, Matthes DJ and Goodman CS:
The semaphorin genes encode a family of transmembrane and secreted
growth cone guidance molecules. Cell. 75:1389–1399. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bahri SM, Chia W and Yang X:
Characterization and mutant analysis of the Drosophila sema 5c
gene. Dev Dyn. 221:322–330. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gras C, Eiz-Vesper B, Jaimes Y, Immenschuh
S, Jacobs R, Witte T, Blasczyk R and Figueiredo C: Secreted
semaphorin 5A activates immune effector cells and is a biomarker
for rheumatoid arthritis. Arthritis Rheumatol. 66:1461–1471. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Arribas J and Borroto A: Protein
ectodomain shedding. Chem Rev. 102:4627–4638. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Simmons AD, Overhauser J and Lovett M:
Isolation of cDNAs from the Cri-du-chat critical region by direct
screening of a chromosome 5-specific cDNA library. Genome Res.
7:118–127. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mosca-Boidron AL, Gueneau L, Huguet G,
Goldenberg A, Henry C, Gigot N, Pallesi-Pocachard E, Falace A,
Duplomb L, Thevenon J, et al: A de novo microdeletion of SEMA5A in
a boy with autism spectrum disorder and intellectual disability.
Eur J Hum Genet. 24:838–843. 2016. View Article : Google Scholar :
|
|
36
|
Sadanandam A, Rosenbaugh EG, Singh S,
Varney M and Singh RK: Semaphorin 5A promotes angiogenesis by
increasing endothelial cell proliferation, migration, and
decreasing apoptosis. Microvasc Res. 79:1–9. 2010. View Article : Google Scholar
|
|
37
|
Sadanandam A, Varney ML, Singh S, Ashour
AE, Moniaux N, Deb S, Lele SM, Batra SK and Singh RK: High gene
expression of semaphorin 5A in pancreatic cancer is associated with
tumor growth, invasion and metastasis. Int J Cancer. 127:1373–1383.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sadanandam A, Varney ML, Kinarsky L, Ali
H, Mosley RL and Singh RK: Identification of functional cell
adhesion molecules with a potential role in metastasis by a
combination of in vivo phage display and in silico analysis. OMICS.
11:41–57. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pan G, Zhang X, Ren J, Lu J, Li W, Fu H,
Zhang S and Li J: Semaphorin 5A, an axon guidance molecule,
enhances the invasion and metastasis of human gastric cancer
through activation of MMP9. Pathol Oncol Res. 19:11–18. 2013.
View Article : Google Scholar
|
|
40
|
Saxena S, Purohit A, Varney ML, Hayashi Y
and Singh RK: Semaphorin-5A maintains epithelial phenotype of
malignant pancreatic cancer cells. BMC Cancer. 18:12832018.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li X and Lee AY: Semaphorin 5A and
plexin-B3 inhibit human glioma cell motility through
RhoGDIα-mediated inactivation of Rac1 GTPase. J Biol Chem.
285:32436–32445. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li X, Law JW and Lee AY: Semaphorin 5A and
plexin-B3 regulate human glioma cell motility and morphology
through Rac1 and the actin cytoskeleton. Oncogene. 31:595–610.
2012. View Article : Google Scholar
|
|
43
|
Lin CY, Chen HJ, Huang CC, Lai LC, Lu TP,
Tseng GC, Kuo TT, Kuok QY, Hsu JL, Sung SY, et al: ADAM9 promotes
lung cancer metastases to brain by a plasminogen activator-based
pathway. Cancer Res. 74:5229–5243. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
45
|
Feinberg AP and Tycko B: The history of
cancer epigenetics. Nat Rev Cancer. 4:143–153. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002. View
Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lin HC, Yeh CC, Chao LY, Tsai MH, Chen HH,
Chuang EY and Lai LC: The hypoxia-responsive lncRNA NDRG-OT1
promotes NDRG1 degradation via ubiquitin-mediated proteolysis in
breast cancer cells. Oncotarget. 9:10470–10482. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
The PONES Correction: Online survival
analysis software to assess the prognostic value of biomarkers
using transcriptomic data in non-small-cell lung cancer. PLoS One.
9:e1118422014. View Article : Google Scholar
|
|
49
|
Győrffy B, Surowiak P, Budczies J and
Lánczky A: Online survival analysis software to assess the
prognostic value of biomarkers using transcriptomic data in
non-small-cell lung cancer. PLoS One. 8:e822412013. View Article : Google Scholar
|
|
50
|
Bild AH, Yao G, Chang JT, Wang Q, Potti A,
Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, et al:
Oncogenic pathway signatures in human cancers as a guide to
targeted therapies. Nature. 439:353–357. 2006. View Article : Google Scholar
|
|
51
|
Director's Challenge Consortium for the
Molecular Classification of Lung Adenocarcinoma. Shedden K, Taylor
JM, Enkemann SA, Tsao MS, Yeatman TJ, Gerald WL, Eschrich S,
Jurisica I, Giordano TJ, et al: Gene expression-based survival
prediction in lung adenocarcinoma: A multi-site, blinded validation
study. Nat Med. 14:822–827. 2008.PubMed/NCBI
|
|
52
|
Selamat SA, Chung BS, Girard L, Zhang W,
Zhang Y, Campan M, Siegmund KD, Koss MN, Hagen JA, Lam WL, et al:
Genome-scale analysis of DNA methylation in lung adenocarcinoma and
integration with mRNA expression. Genome Res. 22:1197–1211. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Roche J, Boldog F, Robinson M, Robinson L,
Varella-Garcia M, Swanton M, Waggoner B, Fishel R, Franklin W,
Gemmill R and Drabkin H: Distinct 3p213 deletions in lung cancer
and identification of a new human semaphorin. Oncogene.
12:1289–1297. 1996.PubMed/NCBI
|
|
54
|
Xiang RH, Hensel CH, Garcia DK, Carlson
HC, Kok K, Daly MC, Kerbacher K, van den Berg A, Veldhuis P, Buys
CH and Naylor SL: Isolation of the human semaphorin III/F gene
(SEMA3F) at chromosome 3p21, a region deleted in lung cancer.
Genomics. 32:39–48. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Pan G, Lv H, Ren H, Wang Y, Liu Y, Jiang H
and Wen J: Elevated expression of semaphorin 5A in human gastric
cancer and its implication in carcinogenesis. Life Sci. 86:139–144.
2010. View Article : Google Scholar
|
|
56
|
Wang DG, Yousif NG, Sadiq AM, Schilling MM
and Danielson X: Critical role of SEMA5A expression in invasion and
metastasis of ovarian cancer cell. Am J Biomed. 2:292–305.
2014.
|
|
57
|
Saxena S, Hayashi Y, Wu L, Awaji M, Atri
P, Varney ML, Purohit A, Rachagani S, Batra SK and Singh RK:
Pathological and functional significance of Semaphorin-5A in
pancreatic cancer progression and metastasis. Oncotarget.
9:5931–5943. 2017.
|
|
58
|
Baylin SB, Esteller M, Rountree MR,
Bachman KE, Schuebel K and Herman JG: Aberrant patterns of DNA
methylation, chromatin formation and gene expression in cancer. Hum
Mol Genet. 10:687–692. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Lenka G, Tsai MH, Hsiao JH, Lai LC and
Chuang EY: Overexpression of methylation-driven DCC suppresses
proliferation of lung cancer cells. Translational Cancer Res.
5:169–175. 2016. View Article : Google Scholar
|
|
60
|
Lenka G, Tsai MH, Lin HC, Hsiao JH, Lee
YC, Lu TP, Lee JM, Hsu CP, Lai LC and Chuang EY: Identification of
methylation-driven, differentially expressed STXBP6 as a novel
biomarker in lung adenocarcinoma. Sci Rep. 7:425732017. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Baumgart A, Seidl S, Vlachou P, Michel L,
Mitova N, Schatz N, Specht K, Koch I, Schuster T, Grundler R, et
al: ADAM17 regulates epidermal growth factor receptor expression
through the activation of Notch1 in non-small cell lung cancer.
Cancer Res. 70:5368–5378. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Sharma A, Bender S, Zimmermann M,
Riesterer O, Broggini-Tenzer A and Pruschy MN: Secretome signature
identifies ADAM17 as novel target for radiosensitization of
non-small cell lung cancer. Clin Cancer Res. 22:4428–4439. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Lv X, Li Y, Qian M, Ma C, Jing H, Wen Z
and Qian D: ADAM17 silencing suppresses the migration and invasion
of non-small cell lung cancer. Mol Med Rep. 9:1935–1940. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Sadanandam A, Sidhu SS, Wullschleger S,
Singh S, Varney ML, Yang CS, Ashour AE, Batra SK and Singh RK:
Secreted semaphorin 5A suppressed pancreatic tumour burden but
increased metastasis and endothelial cell proliferation. Br J
Cancer. 107:501–507. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Hamada K, Oike Y, Ito Y, Maekawa H, Miyata
K, Shimomura T and Suda T: Distinct roles of ephrin-B2 forward and
EphB4 reverse signaling in endothelial cells. Arterioscler Thromb
Vasc Biol. 23:190–197. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Zhang H, Yan D, Shi X, Liang H, Pang Y,
Qin N, Chen H, Wang J, Yin B, Jiang X, et al: Transmembrane
TNF-alpha mediates 'forward' and 'reverse' signaling, inducing cell
death or survival via the NF-kappaB pathway in Raji Burkitt
lymphoma cells. J Leukoc Biol. 84:789–797. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Godenschwege TA, Hu H, Shan-Crofts X,
Goodman CS and Murphey RK: Bi-directional signaling by Semaphorin
1a during central synapse formation in Drosophila. Nat Neurosci.
5:1294–1301. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
68
|
Arakaki AKS, Pan WA, Lin H and Trejo J:
The alpha-arrestin ARRDC3 suppresses breast carcinoma invasion by
regulating G protein-coupled receptor lysosomal sorting and
signaling. J Biol Chem. 293:3350–3362. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Sun Y and Guo Y: Expression of Caspase-1
in breast cancer tissues and its effects on cell proliferation,
apoptosis and invasion. Oncol Lett. 15:6431–6435. 2018.PubMed/NCBI
|
